Ipo5 Rat (-)-demecolcine decreases expression ISO IPO5 (Homo sapiens) 6480464 Demecolcine results in decreased expression of IPO5 mRNA CTD PMID:23649840 Ipo5 Rat (1->4)-beta-D-glucan multiple interactions ISO Ipo5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO5 mRNA CTD PMID:36331819 Ipo5 Rat 1,2-dimethylhydrazine increases expression ISO Ipo5 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in increased expression of IPO5 mRNA CTD PMID:22206623 Ipo5 Rat 1,2-dimethylhydrazine multiple interactions ISO Ipo5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IPO5 mRNA] CTD PMID:22206623 Ipo5 Rat 17alpha-ethynylestradiol multiple interactions ISO Ipo5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO5 mRNA CTD PMID:17942748 Ipo5 Rat 17beta-estradiol decreases expression ISO Ipo5 (Mus musculus) 6480464 Estradiol results in decreased expression of IPO5 mRNA CTD PMID:39298647 Ipo5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ipo5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO5 mRNA CTD PMID:17942748 Ipo5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO IPO5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IPO5 mRNA CTD PMID:21632981 Ipo5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ipo5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IPO5 mRNA CTD PMID:21570461 Ipo5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IPO5 mRNA CTD PMID:21215274 Ipo5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ipo5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IPO5 mRNA CTD PMID:19770486 Ipo5 Rat 2,6-dimethoxyphenol multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the more ... CTD PMID:38598786 Ipo5 Rat 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO IPO5 (Homo sapiens) 6480464 2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of IPO5 protein CTD PMID:32044396 Ipo5 Rat 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of IPO5 mRNA CTD PMID:21061450 Ipo5 Rat 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Ipo5 (Mus musculus) 6480464 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of IPO5 mRNA] CTD PMID:19467301 Ipo5 Rat 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of IPO5 mRNA CTD PMID:30071829 Ipo5 Rat 4,4'-sulfonyldiphenol increases expression ISO IPO5 (Homo sapiens) 6480464 bisphenol S results in increased expression of IPO5 protein CTD PMID:34186270 Ipo5 Rat acrolein multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Ipo5 Rat actinomycin D multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of IPO5 protein CTD PMID:38460933 Ipo5 Rat Aflatoxin B2 alpha increases methylation ISO IPO5 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of IPO5 intron CTD PMID:30157460 Ipo5 Rat all-trans-retinoic acid decreases expression ISO IPO5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of IPO5 mRNA CTD PMID:15498508|PMID:21934132|PMID:33167477 Ipo5 Rat alpha-pinene multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Ipo5 Rat antimycin A increases expression ISO IPO5 (Homo sapiens) 6480464 Antimycin A results in increased expression of IPO5 mRNA CTD PMID:33512557 Ipo5 Rat antirheumatic drug increases expression ISO IPO5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of IPO5 mRNA CTD PMID:24449571 Ipo5 Rat aristolochic acid A decreases expression ISO IPO5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of IPO5 mRNA CTD PMID:33212167 Ipo5 Rat arsenite(3-) multiple interactions ISO IPO5 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to IPO5 mRNA] CTD PMID:32406909 Ipo5 Rat atrazine decreases expression ISO IPO5 (Homo sapiens) 6480464 Atrazine results in decreased expression of IPO5 mRNA CTD PMID:22378314 Ipo5 Rat benzo[a]pyrene increases methylation ISO IPO5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of IPO5 promoter CTD PMID:27901495 Ipo5 Rat benzo[a]pyrene diol epoxide I decreases expression ISO IPO5 (Homo sapiens) 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IPO5 mRNA CTD PMID:26238291 Ipo5 Rat beta-lapachone increases expression ISO IPO5 (Homo sapiens) 6480464 beta-lapachone results in increased expression of IPO5 mRNA CTD PMID:38218311 Ipo5 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IPO5 mRNA CTD PMID:25181051 Ipo5 Rat bisphenol A decreases expression ISO IPO5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of IPO5 protein CTD PMID:37567409 Ipo5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IPO5 mRNA CTD PMID:32145629 Ipo5 Rat bisphenol AF increases expression ISO IPO5 (Homo sapiens) 6480464 bisphenol AF results in increased expression of IPO5 protein CTD PMID:34186270 Ipo5 Rat Bisphenol B increases expression ISO IPO5 (Homo sapiens) 6480464 bisphenol B results in increased expression of IPO5 protein CTD PMID:34186270 Ipo5 Rat bisphenol F increases expression ISO IPO5 (Homo sapiens) 6480464 bisphenol F results in increased expression of IPO5 protein CTD PMID:34186270 Ipo5 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IPO5 mRNA CTD PMID:19167457 Ipo5 Rat calcitriol decreases expression ISO IPO5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of IPO5 mRNA CTD PMID:16847355 Ipo5 Rat carbamazepine affects expression ISO IPO5 (Homo sapiens) 6480464 Carbamazepine affects the expression of IPO5 mRNA CTD PMID:25979313 Ipo5 Rat carbon nanotube increases expression ISO Ipo5 (Mus musculus) 6480464 Nanotubes, Carbon analog results in increased expression of IPO5 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 Ipo5 Rat chlordecone multiple interactions ISO Ipo5 (Mus musculus) 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to IPO5 gene] CTD PMID:31084621 Ipo5 Rat chlorpyrifos decreases expression ISO Ipo5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of IPO5 mRNA CTD PMID:37019170 Ipo5 Rat chromium(6+) affects expression ISO Ipo5 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of IPO5 mRNA CTD PMID:28472532 Ipo5 Rat clofibrate increases expression ISO Ipo5 (Mus musculus) 6480464 Clofibrate results in increased expression of IPO5 mRNA CTD PMID:17585979 Ipo5 Rat cobalt dichloride decreases expression ISO IPO5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of IPO5 mRNA CTD PMID:19320972 Ipo5 Rat cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of IPO5 mRNA CTD PMID:24386269 Ipo5 Rat coumarin affects phosphorylation ISO IPO5 (Homo sapiens) 6480464 coumarin affects the phosphorylation of IPO5 protein CTD PMID:35688186 Ipo5 Rat decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of IPO5 mRNA CTD PMID:23640034 Ipo5 Rat deguelin increases expression ISO IPO5 (Homo sapiens) 6480464 deguelin results in increased expression of IPO5 mRNA CTD PMID:33512557 Ipo5 Rat dicrotophos decreases expression ISO IPO5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of IPO5 mRNA CTD PMID:28302478 Ipo5 Rat dioxygen multiple interactions ISO Ipo5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IPO5 mRNA CTD PMID:30529165 Ipo5 Rat dorsomorphin multiple interactions ISO IPO5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Ipo5 Rat doxorubicin decreases expression ISO IPO5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of IPO5 mRNA CTD PMID:29803840 Ipo5 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of IPO5 mRNA CTD PMID:29391264 Ipo5 Rat enzyme inhibitor multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... CTD PMID:23301498 Ipo5 Rat ethanol affects splicing ISO Ipo5 (Mus musculus) 6480464 Ethanol affects the splicing of IPO5 mRNA CTD PMID:30319688 Ipo5 Rat fenpyroximate increases expression ISO IPO5 (Homo sapiens) 6480464 fenpyroximate results in increased expression of IPO5 mRNA CTD PMID:33512557 Ipo5 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of IPO5 mRNA CTD PMID:30307764 Ipo5 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of IPO5 mRNA CTD PMID:34044035 Ipo5 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of IPO5 mRNA CTD PMID:24136188 Ipo5 Rat folic acid multiple interactions ISO Ipo5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IPO5 mRNA] CTD PMID:22206623 Ipo5 Rat formaldehyde decreases expression ISO IPO5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of IPO5 mRNA CTD PMID:23649840 Ipo5 Rat FR900359 increases phosphorylation ISO IPO5 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of IPO5 protein CTD PMID:37730182 Ipo5 Rat fulvestrant increases methylation ISO IPO5 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of IPO5 gene CTD PMID:31601247 Ipo5 Rat furfural multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of more ... CTD PMID:38598786 Ipo5 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IPO5 mRNA CTD PMID:33387578 Ipo5 Rat hydrogen peroxide affects expression ISO IPO5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of IPO5 mRNA CTD PMID:20044591 Ipo5 Rat indometacin decreases expression ISO IPO5 (Homo sapiens) 6480464 Indomethacin results in decreased expression of IPO5 mRNA CTD PMID:16984733 Ipo5 Rat inulin multiple interactions ISO Ipo5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of IPO5 mRNA CTD PMID:36331819 Ipo5 Rat ivermectin decreases expression ISO IPO5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of IPO5 protein CTD PMID:32959892 Ipo5 Rat ketoconazole decreases expression ISO IPO5 (Homo sapiens) 6480464 Ketoconazole results in decreased expression of IPO5 mRNA CTD PMID:36621641 Ipo5 Rat lead diacetate decreases expression ISO IPO5 (Homo sapiens) 6480464 lead acetate results in decreased expression of IPO5 mRNA CTD PMID:38568856 Ipo5 Rat lovastatin decreases expression ISO Ipo5 (Mus musculus) 6480464 Lovastatin results in decreased expression of IPO5 mRNA CTD PMID:20493250 Ipo5 Rat mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of IPO5 mRNA CTD PMID:16507785 Ipo5 Rat methyl methanesulfonate decreases expression ISO IPO5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of IPO5 mRNA CTD PMID:23649840 Ipo5 Rat methylmercury chloride decreases expression ISO IPO5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of IPO5 mRNA CTD PMID:28001369 Ipo5 Rat miconazole increases expression ISO Ipo5 (Mus musculus) 6480464 Miconazole results in increased expression of IPO5 mRNA CTD PMID:27462272 Ipo5 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of IPO5 mRNA CTD PMID:24136188 Ipo5 Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of IPO5 mRNA CTD PMID:24136188 Ipo5 Rat nitrates multiple interactions ISO Ipo5 (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of IPO5 more ... CTD PMID:35964746 Ipo5 Rat Nutlin-3 multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of IPO5 protein CTD PMID:38460933 Ipo5 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of IPO5 mRNA CTD PMID:25729387 Ipo5 Rat ozone multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Ipo5 Rat paracetamol affects expression ISO Ipo5 (Mus musculus) 6480464 Acetaminophen affects the expression of IPO5 mRNA CTD PMID:17562736 Ipo5 Rat paracetamol decreases expression ISO IPO5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of IPO5 mRNA CTD PMID:21420995 Ipo5 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of IPO5 mRNA CTD PMID:32680482 Ipo5 Rat perfluorohexanesulfonic acid increases expression ISO Ipo5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of IPO5 mRNA CTD PMID:37995155 Ipo5 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Ipo5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO5 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Ipo5 Rat phenylmercury acetate decreases expression ISO IPO5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of IPO5 mRNA CTD PMID:26272509 Ipo5 Rat phenylmercury acetate multiple interactions ISO IPO5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Ipo5 Rat picoxystrobin increases expression ISO IPO5 (Homo sapiens) 6480464 picoxystrobin results in increased expression of IPO5 mRNA CTD PMID:33512557 Ipo5 Rat pirinixic acid increases expression ISO Ipo5 (Mus musculus) 6480464 pirinixic acid results in increased expression of IPO5 mRNA CTD PMID:18301758 Ipo5 Rat SB 431542 multiple interactions ISO IPO5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Ipo5 Rat silicon dioxide affects secretion ISO IPO5 (Homo sapiens) 6480464 Silicon Dioxide analog affects the secretion of IPO5 protein CTD PMID:25895662 Ipo5 Rat sodium arsenite decreases expression ISO IPO5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of IPO5 mRNA CTD PMID:38568856 Ipo5 Rat sodium chloride multiple interactions ISO IPO5 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of more ... CTD PMID:38598786 Ipo5 Rat sodium fluoride increases expression ISO Ipo5 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of IPO5 protein CTD PMID:28918527 Ipo5 Rat sunitinib increases expression ISO IPO5 (Homo sapiens) 6480464 Sunitinib results in increased expression of IPO5 mRNA CTD PMID:31533062 Ipo5 Rat tamibarotene affects expression ISO IPO5 (Homo sapiens) 6480464 tamibarotene affects the expression of IPO5 mRNA CTD PMID:15498508 Ipo5 Rat tebufenpyrad increases expression ISO IPO5 (Homo sapiens) 6480464 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of IPO5 mRNA CTD PMID:33512557 Ipo5 Rat tetrachloroethene increases expression ISO Ipo5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of IPO5 mRNA CTD PMID:28973375 Ipo5 Rat tetrachloromethane increases expression ISO Ipo5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of IPO5 mRNA CTD PMID:27339419|PMID:31919559 Ipo5 Rat thapsigargin increases expression ISO Ipo5 (Mus musculus) 6480464 Thapsigargin results in increased expression of IPO5 protein CTD PMID:24648495 Ipo5 Rat thifluzamide increases expression ISO IPO5 (Homo sapiens) 6480464 thifluzamide results in increased expression of IPO5 mRNA CTD PMID:33512557 Ipo5 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IPO5 mRNA CTD PMID:23411599|PMID:34492290 Ipo5 Rat titanium dioxide increases expression ISO Ipo5 (Mus musculus) 6480464 titanium dioxide results in increased expression of IPO5 mRNA CTD PMID:23557971 Ipo5 Rat titanium dioxide decreases methylation ISO Ipo5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of IPO5 promoter CTD PMID:35295148 Ipo5 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of IPO5 mRNA CTD PMID:25729387 Ipo5 Rat trichostatin A decreases expression ISO IPO5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of IPO5 mRNA CTD PMID:24935251|PMID:26272509 Ipo5 Rat trichostatin A multiple interactions ISO IPO5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Ipo5 Rat trimellitic anhydride increases expression ISO Ipo5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of IPO5 mRNA CTD PMID:19042947 Ipo5 Rat triphenyl phosphate affects expression ISO IPO5 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of IPO5 mRNA CTD PMID:37042841 Ipo5 Rat valproic acid increases methylation ISO IPO5 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of IPO5 gene CTD PMID:29154799 Ipo5 Rat valproic acid affects expression ISO Ipo5 (Mus musculus) 6480464 Valproic Acid affects the expression of KPNB3 mRNA CTD PMID:17292431 Ipo5 Rat valproic acid decreases expression ISO IPO5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IPO5 mRNA CTD PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369 Ipo5 Rat valproic acid multiple interactions ISO IPO5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Ipo5 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of IPO5 mRNA CTD PMID:20566332 Ipo5 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of KPNB3 mRNA CTD PMID:18042343 Ipo5 Rat vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of IPO5 gene CTD PMID:31079544 Ipo5 Rat vincristine decreases expression ISO IPO5 (Homo sapiens) 6480464 Vincristine results in decreased expression of IPO5 mRNA CTD PMID:23649840 Ipo5 Rat warfarin decreases expression ISO Ipo5 (Mus musculus) 6480464 Warfarin results in decreased expression of IPO5 mRNA CTD PMID:20493250